Opal Biosciences, Inc. reported raising $1 Million in an initial SEC Form D filing, from an offering of $75 Million
Amount Raised
$1 Million
Round Type
Seed
Quick answer
Opal Biosciences, Inc. raised $1 Million in a Seed round, dated July 16, 2020. Opal Biosciences, Inc. is based in New York, New York, United States.
- How much did Opal Biosciences, Inc. raise?
- Opal Biosciences, Inc. raised $1 Million in a Seed round on July 16, 2020.
- Where is Opal Biosciences, Inc. based and how big is it?
- Opal Biosciences, Inc. is based in New York, New York, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Opal Biosciences, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Prelude Therapeutics Inc raised $50M on August 28, 2020.
- BirchBioMed Inc. raised $399K (Seed) on August 28, 2020.
- Optimize Systems raised $15M on August 28, 2020.
- Retrotope, Inc. raised $10M on August 28, 2020.
- Genemod Corp raised $1M (Seed) on August 28, 2020.
- Nanotech Energy, Inc. raised $28M on August 28, 2020.
Who to call at Opal Biosciences, Inc., and when
A new round usually means Opal Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Opal Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Opal Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Opal Biosciences, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Opal Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Opal Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.